Teratogens
USMLE Step 1 trap: Confuses lithium's teratogenic effect (Ebstein anomaly) with valproate's neural tube defect association. Lithium causes Ebstein anomaly (tricuspid valve displacement into the right ventricle), not neural tube defects.
Teratogens are one of those topics where the USMLE Step 1 rewards students who know the *specific* outcome for each agent — not just that something is bad in pregnancy. The exam pairs a drug exposure in a vignette with a fetal finding, and if you've mixed up which drug causes which defect, you'll pick the wrong answer confidently. The classic traps are lithium vs. valproate (both used in psychiatric/neurologic conditions, totally different targets), and the miscellaneous group — isotretinoin, thalidomide, DES, warfarin — where each has a signature presentation you need to visualize. Fetal alcohol syndrome is tested on facial features and neurodevelopment, not just 'alcohol is bad.'
The exam tests this from multiple angles: pure recall (what does warfarin cause?), pathophysiology linkage (why does valproate cause neural tube defects?), and clinical vignette reasoning (a patient on lithium has a baby with a heart defect — what is it?). USMLE Step 1 also tests the clinical management side — specifically isotretinoin's iPLEDGE program and why folic acid supplementation is necessary but insufficient against valproate. Passage-based questions may describe a fetal ultrasound finding or a neonatal physical exam and ask you to work backward to the exposure.
The big traps: students conflate lithium with valproate because both are mood stabilizers, but their teratogenic targets are completely different organ systems. Students also overestimate what folate supplementation can do against valproate — it reduces risk, it does not eliminate it. And tetracycline vs. fluoroquinolone gets scrambled under pressure: tooth staining is tetracyclines only, while fluoroquinolones damage cartilage. Getting these straight is the difference between a right and wrong answer on Step 1.
Well-covered in most decks — the challenge is retention, not exposure.
Common misconceptions
What the exam tests
- Know which drugs cause specific fetal cardiac defects — particularly lithium (Ebstein anomaly: tricuspid displacement into the right ventricle) and the cardiac effects of isotretinoin and warfarin.
- Know which drugs cause fetal CNS and neural tube defects — valproate is the key agent, with the mechanism involving inhibition of histone deacetylase and folate metabolism; also know that carbamazepine and methotrexate are relevant here.
- Know which drugs cause fetal bone, tooth, or growth defects — tetracyclines cause tooth discoloration (yellow-brown) and inhibited bone growth; fluoroquinolones cause cartilage damage but not tooth discoloration; ACE inhibitors cause renal dysgenesis and oligohydramnios.
- Recognize the classic teratogen-outcome pairings: thalidomide → phocomelia (limb reduction); DES → vaginal clear cell adenocarcinoma in female offspring; isotretinoin → craniofacial + cardiac + CNS defects; fetal alcohol syndrome → smooth philtrum, thin upper lip, microcephaly, intellectual disability; warfarin → bone/cartilage abnormalities (fetal warfarin syndrome) and CNS defects.
Can you avoid these mistakes?
Related topics
See how your Anki deck covers this topic.
Upload your deck for a free audit →